Psychedelic Medicine

New NORC/BrainFutures Study Finds Psychedelics in Healthcare Practitioner Training is Growing

New NORC/BrainFutures Study Finds Psychedelics in Healthcare Practitioner Training is Growing Research gauged level of clinician workforce preparedness and education in anticipation of possible FDA approval for psychedelic therapies CHICAGO and LUTHERVILLE, MD – December 11, 2024 – In a comprehensive survey of academic leaders from counseling, social work...

Rapid-Acting Mental Health Treatment Summit Aims to Lead the Conversation on What’s Next in Mental Health

November 1, 2023 – BrainFutures, a national nonprofit dedicated to advancing practical applications of new scientific understanding of the brain, will co-host the upcoming Rapid-Acting Mental Health Treatment 2024 (“RAMHT 2024”) an in-person event on January 7th, 2024 in San Francisco. RAMHT 2024 will be jointly led by Dual-boarded Child and Adult Psych...

A Firefighter’s Story: Finding Self-Compassion through MDMA-Assisted Therapy

First responders stand as pillars of strength and courage, but it is easy to forget that even the bravest among us can carry hidden burdens. John, a seasoned fireman, discovered this truth when he stumbled upon a documentary about MDMA-assisted therapy (MDMA-AT) for PTSD. What started as a curiosity led him on a path toward self-discovery. John’s journey...

BrainFutures Releases Psychedelic-Assisted Therapy Coding Guide to Streamline Future Insurance Reimbursement

BrainFutures Releases Psychedelic-Assisted Therapy Coding Guide to Streamline Future Insurance Reimbursement September 25, 2023 – In an effort to make psychedelic-assisted therapy affordable and accessible once it is approved by the U.S. Food and Drug Administration, BrainFutures announces the release of their latest issue brief, A Guide to CPT and HCPCS C...

Reason for Hope, The Veteran Mental Health Leadership Coalition, and BrainFutures Unite to Provide Comments on FDA Guidance for Psychedelic Drugs and Clinical Investigation

Reason for Hope, The Veteran Mental Health Leadership Coalition, and BrainFutures Unite to Provide Comments on FDA Guidance for Psychedelic Drugs and Clinical Investigation August 31, 2023 – A coalition of psychedelic-assisted therapy and mental health advocacy organizations has united to provide collective insight on the psychedelic drug and clinical inve...

American Psychedelic Practitioners Association and BrainFutures Publish First Professional Practice Guidelines for Psychedelic-Assisted Therapy

American Psychedelic Practitioners Association and BrainFutures Publish First Professional Practice Guidelines for Psychedelic-Assisted Therapy First-ever set of professional guidelines informed by clinical research and expert consensus will set benchmarks for practitioners in an emerging field WASHINGTON, August 8, 2023 — The American Psychedelic Prac...

Finding Inner Peace: Li's Journey with Ketamine Treatment

In today’s world, where mental health concerns are increasingly prevalent, it is essential that people who struggle with difficult-to-treat mental health disorders are able to explore evidence-based therapies that offer hope. Ketamine has been shown to be efficacious in rapidly treating depression, suicidality, PTSD, and other mental health and substance use di...

Psychedelic-Assisted Therapy and Primary Care

Primary care is at the front lines of mental healthcare and may soon be at the forefront of psychedelic-assisted therapy. For more on this topic, we invite you to watch our webinar “Psychedelics and Primary Care,” which was moderated by the author.  By Darron Smith Primary care medicine is the bedrock of the healthcare system: it plays a vital role...

Psychedelics and Primary Care Virtual Panel: REGISTER NOW!

Registration for our virtual panel on is now open, but space is limited. [maxbutton id="8" url="https://us06web.zoom.us/webinar/register/WN_4UXnX6OCSOanSDyLa1klNw" text="REGISTER NOW!" ] Panel: Psychedelics and Primary Care  Primary care is at the front lines of our mental health crisis and is often the first point of contact for patients struggling with ...

Kathleen's Story

BrainFutures spoke with a real patient from a psilocybin-assisted therapy study to learn about the lived experiences behind the data on psychedelics. This is Kathleen's story. Kathleen is no stranger to depression, and usually “tends to see the negative side of life really easily.” So when Kathleen was first diagnosed with lymphoma, she found herself t...